30 Jun 2023 11:53
30 June 2023
Medica Group Plc
Result of Annual General Meeting
Medica Group PLC (LSE:MGP, "Medica" or the "Company"), an international provider of high-quality telemedicine services, announces that, at its Annual General Meeting held at 10.30am today at the offices of DLA Piper, 160 Aldersgate Street, London EC1A 4HT, all resolutions put to the meeting were duly passed.
Details of the voting are as follows:
Resolution | For/ Discretion (Number of votes) | % For/ Discretion | Against (Number of votes) | % Against | Total votes
| Withheld (Number of votes) | |
Ordinary Business | |||||||
Ordinary Resolutions | |||||||
1. | To receive and adopt the annual report, accounts and the auditor's report | 66,479,561 | 100.00 | 0 | 0.00 | 66,479,561 | 249,911 |
2. | To approve the Directors' Remuneration Report | 37,121,768 | 57.83 | 27,067,040 | 42.17 | 64,188,808 | 2,540,664 |
3. | To declare a final dividend | See note below* | |||||
4. | To re-appoint Grant Thornton UK LLP as auditors | 66,081,401 | 99.40 | 399,054 | 0.60 | 66,480,455 | 249,017 |
5. | To authorise the Directors to determine the remuneration of the auditors | 66,716,249 | 99.98 | 10,759 | 0.02 | 66,727,008 | 2,464 |
6. | To re-elect Roy Davis as a Director | 65,870,471 | 99.21 | 526,381 | 0.79 | 66,396,852 | 332,620 |
7. | To re-elect Barbara Moorhouse as a Director | 66,204,304 | 99.22 | 522,538 | 0.78 | 66,726,842 | 2,630 |
8. | To re-elect Joanne Easton as a Director | 66,204,415 | 99.21 | 524,189 | 0.79 | 66,728,604 | 868 |
9. | To re-elect Dr Junaid Bajwa as a Director | 65,093,295 | 97.92 | 1,384,696 | 2.08 | 66,477,991 | 251,481 |
10. | To re-elect Stuart Quin as a Director | 66,726,029 | 100.00 | 813 | 0.00 | 66,726,842 | 2,630 |
11. | To re-elect Richard Jones as a Director | 66,477,880 | 100.00 | 111 | 0.00 | 66,477,991 | 251,481 |
Special Business | |||||||
Ordinary resolution | |||||||
12. | General authority to allot shares pursuant to Section 551 Companies Act 2006 | 66,717,902 | 99.99 | 8,940 | 0.01 | 66,726,842 | 2,630 |
Special resolutions | |||||||
13. | Standard pre-emption disapplication | 64,925,423 | 97.30 | 1,800,717 | 2.70 | 66,726,140 | 3,332 |
14. | Additional pre-emption disapplication for the purpose of financing an acquisition or other capital investment | 64,672,763 | 96.92 | 2,053,377 | 3.08 | 66,726,140 | 3,332 |
15. | Authority to make market purchases of up to 12,288,363 shares | 65,844,437 | 99.62 | 248,149 | 0.38 | 66,092,586 | 636,886 |
16. | To authorise general meetings to be held on 14 clear days' notice | 66,165,995 | 99.16 | 562,609 | 0.84 | 66,728,604 | 868 |
* As previously communicated by an RNS announcement this morning, the resolution to declare a final dividend for the year ended 31 December 2022 of 1.88 pence per share ("2022 Final Dividend") (Resolution 3) was withdrawn prior to, and was not presented to, the AGM. This will ensure shareholders receive 212 pence per share in full without any reduction in respect of the previously proposed 2022 Final Dividend as opposed to two separate payments and in accordance with the terms of the recommended cash acquisition for the Company by Moonlight Bidco Limited (once effected).
For further information, please contact:
Medica Group Plc: Stuart Quin, Chief Executive Officer Richard Jones, Chief Financial Officer
| +44 (0)33 33 111 222
|
FTI Consulting Victoria Foster Mitchell Sam Purewal
| +44 (0)20 3727 1000 |
Liberum (Joint Broker) Phil Walker Richard Lindley
| +44 (0)20 3100 2000 |
Numis (Joint Broker) Freddie Barnfield Duncan Monteith Euan Brown
| +44 (0)20 7260 1000
|
About Medica Group PLC
Medica (LSE:MGP) is an international provider of high-quality telemedicine services. It is the market leader in teleradiology in the UK and Ireland, working with more than 100 NHS Trusts and HSE hospitals in Ireland, in addition to private hospitals, insurance groups and diagnostic imaging companies. Its network of consultant radiologists, radiographers and specialist doctors interpret and report MRI, CT, ultrasound and X-ray images on behalf of healthcare providers, using Medica's bespoke, secure technology platform for fast and responsive delivery. The company's core services include NightHawk, an urgent, out-of-hours offering available to clients 24/7 with dedicated pathways for stroke and major trauma, and Elective, for routine reporting.
In Ireland, Medica carries out patient scanning, as well as reporting, and runs a diabetic retinopathy screening programme for the National Screening Service. Through its US business, RadMD, Medica provides global pharmaceutical and biotech companies, as well as contract research organisations with specialist imaging services for clinical trials.
For more information please visit: www.medicagroupplc.com